DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...
Morgan Stanley lowered the firm’s price target on DexCom (DXCM) to $63 from $89 and keeps an Overweight rating on the shares. Published first on ...
Barchart on MSN
DexCom Stock: Is Wall Street Bullish or Bearish?
DexCom, Inc. (DXCM), headquartered in San Diego, California, is a leading medical-device company that designs, develops and ...
Dexcom welcomed the advocates to a photoshoot in Los Angeles that included Grammy-nominated artist, actor, producer and ...
Dexcom’s World Diabetes Day campaign provides a platform for the selected individuals to advocate for diabetes awareness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback